Chemical and structural modifications of pulmonary collectins and their functional consequences

Innate Immunity

Volumn 16, Issue 3, 2010, Pages 175-182

  Atochina Vasserman, Elena N ^a   Beers, Michael F ^a   Gow, Andrew J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Biomarker; Collectins; Lung; Nitric oxide; Surfactant proteins

Indexed keywords

COLLECTIN; CYTOKINE; NITRIC OXIDE; NITROGEN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; AUTACOID;

ALLERGIC DISEASE; ASTHMA; CROSS LINKING; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; INFLUENZA VIRUS A; INNATE IMMUNITY; NITRATION; NITROSYLATION; NONHUMAN; OLIGOMERIZATION; OXIDATION; PATHOGENESIS; PNEUMOCYSTIS; PNEUMONIA; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; ANIMAL; ANTIGEN ANTIBODY REACTION; BACTERIUM ADHERENCE; CHEMISTRY; IMMUNOLOGY; LUNG; METABOLISM; MOUSE; PROTEIN MULTIMERIZATION;

INFLUENZA A VIRUS; PNEUMOCYSTIS MURINA;

AGGLUTINATION; ANIMALS; BACTERIAL ADHESION; COLLECTINS; HUMANS; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS; LUNG; MICE; PNEUMOCYSTIS; PROTEIN MULTIMERIZATION; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 77953315227     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910368871     Document Type: Review

References (50)

1. Gaston B., Sears S., Woods J. et al. Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet 1998 ; 351: 1317-1319.
2. Dellinger RP Inhaled nitric oxide in acute lung injury and acute respiratory distress syndrome. Inability to translate physiologic benefit to clinical outcome benefit in adult clinical trials. Intensive Care Med 1999 ; 25: 881-883.
3. Beckman JS, Koppenol WH Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996 ; 271: C1424 - C1437.
4. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998 ; 356: 1-11.
5. Gow AJ, Chen Q., Hess DT et al. Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J Biol Chem 2002 ; 277: 9637-9640.
6. Wu W., Chen Y., Hazen SL Eosinophil peroxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999 ; 274: 25933-25944.
7. Floris R., Piersma SR, Yang G. et al. Interaction of myeloperoxidase with peroxynitrite. A comparison with lactoperoxidase, horseradish peroxidase and catalase. Eur J Biochem 1993 ; 215: 767-775.
8. Stamler JS, Jaraki O., Osborne J. et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992 ; 89: 7674-7677.
9. Stamler JS, Lamas S., Fang FC Nitrosylation. the prototypic redox-based signaling mechanism. Cell 2001 ; 106: 675-683.
10. Gow AJ, Farkouh CR, Munson DA et al. Biological significance of nitric oxide-mediated protein modifications. Am J Physiol 2004 ; 287: L262 - L268.
11. Greco TM, Hodara R., Parastatidis I. et al. Identification of Snitrosylation motifs by site-specific mapping of the S-nitrosocysteine proteome in human vascular smooth muscle cells. Proc Natl Acad Sci USA 2006 ; 103: 7420-7425.
12. Hess DT, Matsumoto A., Kim SO et al. Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005 ; 6: 150-166.
13. Gow AJ, Ischiropoulos H. Nitric oxide chemistry and cellular signaling. J Cell Physiol 2001 ; 187: 277-282.
14. Gaston B., Singel D., Doctor A. et al. S-nitrosothiol signaling in respiratory biology. Am J Respir Crit Care Med 2006 ; 173: 1186-1193.
15. Brown-Augsburger P., Chang D., Rust K. et al. Biosynthesis of surfactant protein D. Contributions of conserved NH2-terminal cysteine residues and collagen helix formation to assembly and secretion. J Biol Chem 1996 ; 271: 18912-18919.
16. Spissinger T., Schafer KP, Voss T. Assembly of the surfactant protein SP-A. Deletions in the globular domain interfere with the correct folding of the molecule. Eur J Biochem 1991 ; 199: 65-71.
17. Hansen S., Holm D., Moeller V. et al. CL-46, a novel collectin highly expressed in bovine thymus and liver. J Immunol 2002 ; 169: 5726-5734.
18. Crouch E., Persson A., Chang D. et al. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994 ; 269: 17311-17319.
19. Whitsett JA, Hull W., Ross G. et al. Characteristics of human surfactant-associated glycoproteins A. Pediatr Res 1985 ; 19: 501-508.
20. Wang G., Bates-Kenney SR, Tao JQ et al. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry 2004 ; 43: 4227-4239.
21. Sanchez-Barbero F., Strassner J., Garcia-Canero R. et al. Role of the degree of oligomerization in the structure and function of human surfactant protein A. J Biol Chem 2005 ; 280: 7659-7670.
22. Voss T., Melchers K., Scheirle G. et al. Structural comparison of recombinant pulmonary surfactant protein SP-A derived from two human coding sequences: implications for the chain composition of natural human SP-A. Am J Respir Cell Mol Biol 1991 ; 4: 88-94.
23. Phelps DS, Floros J., Taeusch Jr HW. Post-translational modification of the major human surfactant-associated proteins. Biochem J 1986 ; 237: 373-377.
24. McCormack FX Structure, processing and properties of surfactant protein A. Biochim Biophys Acta 1998 ; 1408: 109-131.
25. Benne CA, Benaissa-Trouw B., van Strijp JA et al. Surfactant protein A, but not surfactant protein D, is an opsonin for influenza A virus phagocytosis by rat alveolar macrophages. Eur J Immunol 1997 ; 27: 886-890.
26. Zhu S., Ware LB, Geiser T. et al. Increased levels of nitrate and surfactant protein a nitration in the pulmonary edema fluid of patients with acute lung injury. Am J Respir Crit Care Med 2001 ; 163: 166-172. (Pubitemid 32097973)
27. Zhu S., Kachel DL, Martin WJ et al. Nitrated SP-A does not enhance adherence of Pneumocystis carinii to alveolar macrophages. Am J Physiol 1998 ; 275: L1031 - L1039.
28. Haddad IY, Zhu S., Ischiropoulos H. et al. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol 1996 ; 270: L281 - L288.
29. Davis IC, Zhu S., Sampson JB et al. Inhibition of human surfactant protein A function by oxidation intermediates of nitrite. Free Radic Biol Med 2002 ; 33: 1703-1713.
30. Yamada C., Sano H., Shimizu T. et al. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J Biol Chem 2006 ; 281: 21771-21780.
31. Pastva AM, Wright JR, Williams KL Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 2007 ; 4: 252-257.
32. Crouch E., Chang D., Rust K. et al. Recombinant pulmonary surfactant protein D. Post-translational modification and molecular assembly. J Biol Chem 1994 ; 269: 15808-15813.
33. Hakansson K., Lim NK, Hoppe HJ et al. Crystal structure of the trimeric alpha-helical coiled-coil and the three lectin domains of human lung surfactant protein D. Structure 1999 ; 7: 255-264.
34. Zhang L., Ikegami M., Crouch EC et al. Activity of pulmonary surfactant protein-D (SP-D) in vivo is dependent on oligomeric structure. J Biol Chem 2001 ; 276: 19214-19219.
35. Guo CJ, Atochina-Vasserman EN, Abramova E. et al. S-Nitrosylation of surfactant protein-D controls inflammatory function. PLoS Biol 2008 ; 6: e266.
36. Matalon S., Shrestha K., Kirk M. et al. Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo. FASEB J 2009 ; 23: 1415-1430.
37. Sorensen GL, Husby S., Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007 ; 212: 381-416.
38. Leth-Larsen R., Garred P., Jensenius H. et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005 ; 174: 1532-1538.
39. Heidinger K., Konig IR, Bohnert A. et al. Polymorphisms in the human surfactant protein-D (SFTPD) gene: strong evidence that serum levels of surfactant protein-D (SP-D) are genetically influenced. Immunogenetics 2005 ; 57: 1-7.
40. Hartshorn KL, Crouch E., White MR et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998 ; 274: L958 - L969.
41. Lahti M., Lofgren J., Marttila R. et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002 ; 51: 696-699. (Pubitemid 34547331)
42. Floros J., Lin HM, Garcia A. et al. Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis 2000 ; 182: 1473-1478.
43. Hartshorn KL, White MR, Tecle T. et al. Reduced influenza viral neutralizing activity of natural human trimers of surfactant protein D. Respir Res 2007 ; 8: 9.
44. Griese M., Maderlechner N., Ahrens P. et al. Surfactant proteins A and D in children with pulmonary disease due to gastroesophageal reflux. Am J Respir Crit Care Med 2002 ; 165: 1546-1550.
45. Starosta V., Rietschel E., Paul K. et al. Oxidative changes of bronchoalveolar proteins in cystic fibrosis. Chest 2006 ; 129: 431-437.
46. Yamazoe M., Nishitani C., Takahashi M. et al. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 2008 ; 283: 35878-35888.
47. White M., Kingma P., Tecle T. et al. Multimerization of surfactant protein D, but not its collagen domain, is required for antiviral and opsonic activities related to influenza virus. J Immunol 2008 ; 181: 7936-7943.
48. Atochina-Vasserman EN, Winkler C., Abramova H. et al. Segmental antigen challenge produces alterations in surfactant protein D expression and multimeric structure in humans. Am J Respir Crit Care Med 2009 ; 179: A6272.
49. Gardai SJ, Xiao YQ, Dickinson M. et al. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003 ; 115: 13-23.
50. Atochina-Vasserman EN, Gow AJ, Abramova H. et al. Immune reconstitution during Pneumocystis lung infection: disruption of surfactant component expression and function by S-nitrosylation. J Immunol 2009 ; 182: 2277-2287.